A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients. 1978

F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman

UI MeSH Term Description Entries
D008297 Male Males
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
January 2002, European journal of clinical pharmacology,
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
January 1985, The Journal of international medical research,
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
January 1991, Pharmacopsychiatry,
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
January 1981, Psychopharmacology bulletin,
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
October 1988, Medizinische Klinik (Munich, Germany : 1983),
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
November 1980, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
April 1988, Behavioral neuroscience,
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
January 1996, Neurologia (Barcelona, Spain),
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
October 1983, Ceskoslovenska psychiatrie,
F S Abuzzahab, and G E Merwin, and R L Zimmermann, and M C Sherman
January 1984, Neuropsychobiology,
Copied contents to your clipboard!